Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection

Virology

Volumn 316, Issue 1, 2003, Pages 161-170

  Yoshida, Shigeto ^a   Kondoh, Daisuke ^a   Arai, Eriko ^a   Matsuoka, Hiroyuki ^a   Seki, Chisato ^a   Tanaka, Takao ^b   Okada, Masaji ^b   Ishii, Akira ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Baculovirus; Circumsporozoite protein; gp64; Malaria; Plasmodium berghei; Vaccine; Viral vector

Indexed keywords

ANTIBODY; GAMMA INTERFERON; GLYCOPROTEIN GP 64; IMMUNOLOGICAL ADJUVANT; MALARIA VACCINE; PLASMODIUM BERGHEI CIRCUMSPOROZOITE PROTEIN; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; VIRUS VECTOR;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOGRAPHA CALIFORNICA NUCLEAR POLYHEDROSIS VIRUS; BACULOVIRUS; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE DELIVERY SYSTEM; HEPATOMA CELL; HUMAN; HUMAN CELL; MALARIA; MOUSE; NONHUMAN; OLIGOMERIZATION; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN BINDING; RODENT; SPOROZOITE; VIRION; VIRUS ENVELOPE; VIRUS RECOMBINANT;

PLASMODIUM BERGHEI; RODENTIA; UNIDENTIFIED BACULOVIRUS;

EID: 0242352463     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.08.003     Document Type: Article

References (32)

1. Boublik Y., Di Bonito P., Jones I.M. Eukaryotic virus display engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface . Biotechnology. 13:1995;1079-1084.
2. Boyce F.M., Bucher N.L. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. USA. 93:1996;2348-2352.
3. Cerami C., Frevert U., Sinnis P., Takacs B., Clavijo P., Santos M.J., Nussenzweig V. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell. 70:1992;1021-1033.
4. Cerami C., Frevert U., Sinnis P., Takacs B., Nussenzweig V. Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. J. Exp. Med. 179:1994;695-701.
5. Charoenvit Y., Leef M.F., Yuan L.F., Sedegah M., Beaudoin R.L. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect. Immun. 55:1987;604-608.
6. Church L.W., Le T.P., Bryan J.P., Gordon D.M., Edelman R., Fries L., Davis J.R., Herrington D.A., Clyde D.F., Shmuklarsky M.J., Schneider I., McGovern T.W., Chulay J.D., Ballou W.R., Hoffman S.L. Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J. Infect. Dis. 175:1997;915-920.
7. Condreay J.P., Witherspoon S.M., Clay W.C., Kost T.A. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. Sci. USA. 96:1999;127-132.
8. Currier J.R., Kuta E.G., Turk E., Earhart L.B., Loomis-Price L., Janetzki S., Ferrari G., Birx D.L., Cox J.H. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J. Immunol. Methods. 260:2002;157-172.
9. Doolan D., Hoffman S.L. Multi-gene vaccination against malaria a multistage, multi-immune responses approach . Parasitol. Today. 13:1997;171-178.
10. Eichinger D.J., Arnot D.E., Tam J.P., Nussenzweig V., Enea V. Circumsporozoite protein of Plasmodium berghei gene cloning and identification of the immunodominant epitopes . Mol. Cell Biol. 6:1986;3965-3972.
11. Grabherr R., Ernst W., Oker-Blom C., Jones I. Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins. Trends. Biotechnol. 19:2001;231-236.
12. Hoffman, S.L., Franke, E.D., Hollingdale, M.R., Druilhe, P., 1996, in: Hoffman, S.L. (Ed.), Malaria Vaccine Development, Am. Soc. Microbiol., Washington, DC.
13. Hofmann C., Sandig V., Jennings G., Rudolph M., Schlag P., Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. USA. 92:1995;10099-10103.
14. Huser A., Rudolph M., Hofmann C. Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nat. Biotechnol. 19:2001;451-455.
15. Kaba S.A., Hemmes J.C., van Lent J.W., Vlak J.M., Nene V., Musoke A.J., van Oers M.M. Baculovirus surface display of Theileria parva p67 antigen preserves the conformation of sporozoite-neutralizing epitopes. Protein Eng. 16:2003;73-78.
16. Leitner W.W., Seguin M.C., Ballou W.R., Seitz J.P., Schultz A.M., Sheehy M.J., Lyon J.A. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159:1997;6112-6119.
17. Mottershead D., van der Linden I., von Bonsdorff C.H., Keinanen K., Oker-Blom C. Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. Biochem. Biophys. Res. Commun. 238:1997;717-722.
18. Mottershead D.G., Alfthan K., Ojala K., Takkinen K., Oker-Blom C. Baculoviral display of functional scFv and synthetic IgG-binding domains. Biochem. Biophys. Res. Commun. 275:2000;84-90.
19. Ockenhouse C.F., Sun P.F., Lanar D.E., Wellde B.T., Hall B.T., Kester K., Stoute J.A., Magill A., Krzych U., Farley L., Wirtz R.A., Sadoff J.C., Kaslow D.C., Kumar S., Church L.W., Crutcher J.M., Wizel B., Hoffman S., Lalvani A., Hill A.V., Tine J.A., Guito K.P., de Taisne C., Anders R., Ballou W.R., et al. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J. Infect. Dis. 177:1998;1664-1673.
20. Rathore D., McCutchan T.F. Role of cysteines in Plasmodium falciparum circumsporozoite protein interactions with heparin can rejuvenate inactive protein mutants . Proc. Natl. Acad. Sci. USA. 97:2000;8530-8535.
21. Rathore D., Sacci J.B., de la Vega P., McCutchan T.F. Binding and invasion of liver cells by Plasmodium falciparum sporozoites essential involvement of the amino terminus of circumsporozoite protein . J. Biol. Chem. 277:2002;7092-7098.
22. Sandig V., Hofmann C., Steinert S., Jennings G., Schlag P., Strauss M. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum. Gene Ther. 7:1996;1937-1945.
23. Sauzet J.P., Perlaza B.L., Brahimi K., Daubersies P., Druilhe P. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge. Infect. Immun. 69:2001;1202-1206.
24. Shoji I., Aizaki H., Tani H., Ishii K., Chiba T., Saito I., Miyamura T., Matsuura Y. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J. Gen. Virol. 78:1997;2657-2664.
25. Sinnis P. The malaria sporozoite's journey into the liver. Infect. Agents Dis. 5:1996;182-189.
26. Sinnis P., Clavijo P., Fenyo D., Chait B.T., Cerami C., Nussenzweig V. Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J. Exp. Med. 180:1994;297-306.
27. Stoute J.A., Slaoui M., Heppner D.G., Momin P., Kester K.E., Desmons P., Wellde B.T., Garcon N., Krzych U., Marchand M. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS, S Malaria Vaccine Evaluation Group. N. Engl. J. Med. 336:1997;86-91.
28. Tami C., Farber M., Palma E.L., Taboga O. Presentation of antigenic sites from foot-and-mouth disease virus on the surface of baculovirus and in the membrane of infected cells. Arch. Virol. 145:2000;1815-1828.
29. Tani H., Nishijima M., Ushijima H., Miyamura T., Matsuura Y. Characterization of cell-surface determinants important for baculovirus infection. Virology. 279:2001;343-353.
30. Vaughan J.A., Scheller L.F., Wirtz R.A., Azad A.F. Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite implications for sporozoite vaccine trials . Infect. Immun. 67:1999;4285-4289.
31. Yoshida S., Kashiwamura S., Hosoya Y., Luo E., Matsuoka H., Ishii A., Fujimura A., Kobayashi E. Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite. Biochem. Biophys. Res. Commun. 271:2000;107-115.
32. Yoshida S., Matsuoka H., Luo E., Iwai K., Arai M., Sinden R.E., Ishii A. A single-chain antibody fragment specific for the Plasmodium berghei ookinete protein Pbs21 confers transmission blockade in the mosquito midgut. Mol. Biochem. Parasitol. 104:1999;195-204.